Table 1.
Characteristics | Recently attacked RAAU (Case, n = 39) | Quiescent RAAU (Control, n = 39) |
---|---|---|
Mean age in years (SD) | 50.7 (11.0) | 50.9 (11.3) |
Female (%) | 25 (64.1) | 25 (64.1) |
HLA-B27 positivity (%) | 32 (82.1) | 32 (82.1) |
Unilateral involvement (%) | 38 (97.4) | 34 (87.2) |
Smoking | 0 | 0 |
Presence of immunological or allergic diseases (%) | 17 (43.6) | 16 (41.0) |
Current anti-inflammatory agents* (%) | 6 (15.4) | 8 (20.5) |
Median number of anterior uveitis episodes (min–max) | 2 (2–7) | 2 (1–9) |
Median A/C cells (min–max) | 3 (0.5–4) | 0 |
RAAU recurrent acute anterior uveitis, SD standard deviation, HLA-B27 human leukocyte antigen-B27, A/C anterior chamber, min minimum, max maximum.
*Systemic anti-inflammatory agents used in control of coexisting systemic autoimmune diseases.